1. Amoxicillin + Clavulanic Acid (Co-amoxiclav)

7. Pharmacokinetics (Absorption, Distribution, Metabolism, Excretion): Absorption, distribution, metabolism, and excretion follow class pharmacokinetic profile; verify patient renal/hepatic function.

16a. Renal Considerations: Renal: Strictly renal-function dependent! • Do NOT use the 1000 mg (875/125 mg) tablet if CrCl <30 mL/min! • CrCl 10–30 mL/min: 625 mg (500/125 mg) twice daily. • CrCl <10 mL/min: 625 mg once every 24 hours. Hepatic: Contraindicated in prior co-amoxiclav jaundice; monitor LFTs if used >10–14 days in liver disease.

16b. Hepatic Considerations: Renal: Strictly renal-function dependent! • Do NOT use the 1000 mg (875/125 mg) tablet if CrCl <30 mL/min! • CrCl 10–30 mL/min: 625 mg (500/125 mg) twice daily. • CrCl <10 mL/min: 625 mg once every 24 hours. Hepatic: Contraindicated in prior co-amoxiclav jaundice; monitor LFTs if used >10–14 days in liver disease.

• Antibiotic-associated diarrhoea (10–25%, driven by clavulanic acid stimulating small-bowel motility and altering flora), nausea, abdominal cramping, mucocutaneous candidiasis (thrush/vaginitis), skin rash.
• Drug-Induced Cholestatic Jaundice / Hepatitis (clavulanic acid idiosyncratic reaction—more common in men and elderly patients >65 years, and can appear during therapy or up to 2 to 6 weeks AFTER completing the course!), anaphylaxis, C. difficile colitis, SJS/TEN.

• Warfarin / Acitrom: Potentiates anticoagulation and causes major INR spikes—check INR within 3–5 days of starting Augmentin! Allopurinol (increased rash)
• Methotrexate (reduced renal clearance)
• Mycophenolate mofetil levels reduced

15. Use in Special Populations (Pregnancy, Lactation, Paediatrics, Geriatrics): Evaluate maternal-foetal benefit-risk ratio, paediatric mg/kg ceiling, and geriatric renal function prior to prescribing.

17. Clinical & Laboratory Monitoring: Monitor clinical response, baseline renal/hepatic parameters, and relevant serum biomarkers.

• Patient Counselling Checklist: 1. Take right at the start of your meal to prevent loose motions. 2. Blister Moisture Alert: Clavulanic acid is extremely hygroscopic (absorbs humidity from Indian monsoon/summer air and turns soft, sticky, and dark brown, losing all potency)—keep strips sealed inside their outer aluminium desiccant pouch and never pop tablets out into weekly pill boxes in advance! 3. Reconstituted paediatric Augmentin Duo syrups MUST be stored in the refrigerator (2°C–8°C) and discarded after 7 days!
• Meal & Clock Timing Instruction: MUST be taken AT THE START OF A MEAL! (Taking at the very beginning of breakfast, lunch, and dinner optimises clavulanate absorption and markedly reduces clavulanic-acid-induced gastrointestinal cramping and diarrhoea). (Every 8 hours (with breakfast, lunch, dinner for 625 mg TDS) or every 12 hours (with breakfast and dinner for 625 mg BD / 1000 mg BD).)
• Missed Dose Protocol: Take with food as soon as remembered; maintain regular spacing for remaining tablets.
• Geriatric Dispensing Pearl: Elderly men (>65 years) have the highest risk of clavulanate-induced cholestatic jaundice (which may present weeks after finishing the strip) and C. difficile diarrhoea. Avoid the 1000 mg strength if CrCl <30 mL/min.

Storage & Dispensing Notes: COLD CHAIN MANDATORY (2°C–8°C): Store in a pharmaceutical refrigerator between 2°C and 8°C; DO NOT FREEZE. Protect from light and heat during dispensing.